Algeria explores local manufacturing of glucose monitoring devices with Abbott

The Algerian Ministry of Pharmaceutical Industry has held talks with representatives from the American laboratory Abbott regarding the local production of advanced continuous glucose monitoring devices. This initiative is part of a broader goal to localize medical technology and improve access for diabetic patients, with a specific focus on children. The meeting in Algiers included officials from the ministry, the head of the Algerian-American Business Council, and delegates from the National Agency for Pharmaceutical Products and the Saidal group.